What this video covers
A video from ARDD, posted on Oct 26, 2026. It is about measuring biological age, drugs tested against aging and the science of aging. It names Rapamycin.
It comes from a research institute, foundation or scientific meeting on aging. We link to it; we don't make or endorse it. Research stages on this site come from published studies, not from videos.
Measuring biological age: the research →Drugs tested against aging: the research →The science of aging: the research →
From the video's description
Dan Promislow, HNRCA at Tufts University, presents at the 13th Aging Research and Drug Discovery Meeting: The Companion Dog as a Translational Model of Aging Key takeaways: – More than 55,000 dogs enrolled since 2020; a Precision Cohort of ~1,000 dogs gives annual biospecimens; data shared via the Broad's Terra. – NIA renewed funding for five more years; a new cohort of ~1,000 of the oldest U.S. dogs will get 30x genomes; the Precision Cohort could grow to 3,000 and add transcriptome, proteome and lipidome with more support. – Dogs with lower epigenetic age live longer; genes hypomethylated with age in dogs tend to rise in expression in aging humans. – 25 metabolites (enriched for kidney markers) predict mortality in dogs and in the same direction in humans, found with 2.6 years of follow-up vs. 8–25 in human studies. – GWAS linked a chromosome 25 SNP to kynurenic acid; coat "furnishing…
Written by ARDD on YouTube.
More videos like this
Research institutePhilipp Gut at ARDD2026: Nutrition to slow biological aging in dogsMeasuring biological age
Research instituteAlex Zhavoronkov at ARDD2026: Aging-first Drug Discovery with MMAI and Longevity Foundation ModelsMeasuring biological age
Research instituteKirsten Seale at ARDD2026: From Infrastructure to InsightGLP-1 drugs · Stage 4 of 4
Research instituteKevin Duffin at ARDD2026: Modulation of Aging Clocks by the GLP-1/GIP dual agonist, TirzepatideGLP-1 drugs · Stage 4 of 4